Specifically, MIF was shown to act as a chaperone for SOD1, thus suppressing misfolded SOD1 accumulation and maintaining SOD1 activity. This way, the cancer cells, which express high levels of MIF, become resistant to proteasome inhibitor treatment in human myeloma44. This evidence concerns the gene MIF and cancer.